Global blood banking market set to be driven by health scares and regulatory requirements

The global blood banking market has been forecast to hit a valuation of US$43 billion by 2018, with the industry set to be driven by health scares and regulatory requirements. Worldwide markets for blood banking are exhibiting a healthy trend, thanks to an aging population, and a steep increase in healthcare expenditures.

Though temporarily impacted by the economic recession, new infections continue to take a toll on population in developing nations, fuelling demand for blood banking and blood products. Regulatory and healthcare bodies across the world, in a bid to serve these people, are adopting stringent policies relating to blood safety.

As an extension to this, manufacturers all over the world are developing improved, safer, and advanced blood banking technologies for the collection, processing and delivery of blood products.

Blood is an essential substance for life and is utilised in the healthcare system. Its collection and its subsequent usage from purchased or donated sources is a concern of hospitals and other surgical centres.

There are specific devices and blood collection equipment used in the process. In the course of its usage, blood is tested; both for its type so that a proper recipient can be matched and to be sure the blood is clear of infection.

The worldwide production of blood plasma products is considerably lesser than demand, which for some products is rising at a rate of 14.6% each year. Fractionating facilities are also decreasing in number, increasing the burden on the remaining sources. The industry is rendered vulnerable to economic fluctuations and export regulations.

For more information on the global blood banking market, see the latest research: Global Blood Banking Market

Follow us on Twitter @CandMResearch